首页> 美国卫生研究院文献>Therapeutic Advances in Gastroenterology >Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
【2h】

Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

机译:益生菌酿酒酵母预防和治疗胃肠道疾病的功效和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several clinical trials and experimental studies strongly suggest a place for Saccharomyces boulardii as a biotherapeutic agent for the prevention and treatment of several gastrointestinal diseases. S. boulardii mediates responses resembling the protective effects of the normal healthy gut flora. The multiple mechanisms of action of S. boulardii and its properties may explain its efficacy and beneficial effects in acute and chronic gastrointestinal diseases that have been confirmed by clinical trials. Caution should be taken in patients with risk factors for adverse events. This review discusses the evidence for efficacy and safety of S. boulardii as a probiotic for the prevention and therapy of gastrointestinal disorders in humans.
机译:数项临床试验和实验研究强烈建议将布拉氏酵母作为生物治疗剂用于预防和治疗几种胃肠道疾病。猪链球菌介导类似于正常健康肠道菌群的保护作用的反应。猪链球菌的多种作用机制及其特性可能解释了其在急性和慢性胃肠道疾病中的功效和有益作用,这些已被临床试验证实。有不良事件危险因素的患者应注意。这篇综述讨论了作为预防和治疗人类胃肠道疾病的益生菌,S。boulardii的功效和安全性的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号